17,575 Shares in Cencora, Inc. $COR Purchased by Lombard Odier Asset Management Switzerland SA

Lombard Odier Asset Management Switzerland SA acquired a new position in shares of Cencora, Inc. (NYSE:COR) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 17,575 shares of the company’s stock, valued at approximately $5,936,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of COR. Atom Investors LP increased its position in shares of Cencora by 41.6% during the fourth quarter. Atom Investors LP now owns 21,942 shares of the company’s stock valued at $7,411,000 after acquiring an additional 6,448 shares during the last quarter. Clark Capital Management Group Inc. grew its stake in Cencora by 0.9% during the 4th quarter. Clark Capital Management Group Inc. now owns 253,639 shares of the company’s stock worth $85,666,000 after purchasing an additional 2,172 shares in the last quarter. Kemnay Advisory Services Inc. purchased a new position in shares of Cencora in the 4th quarter valued at about $25,000. State of Wisconsin Investment Board grew its position in shares of Cencora by 3.7% during the fourth quarter. State of Wisconsin Investment Board now owns 104,892 shares of the company’s stock worth $35,427,000 after buying an additional 3,763 shares in the last quarter. Finally, Captrust Financial Advisors raised its holdings in Cencora by 24.2% in the fourth quarter. Captrust Financial Advisors now owns 22,706 shares of the company’s stock valued at $7,669,000 after acquiring an additional 4,428 shares in the last quarter. 97.52% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have commented on COR shares. Leerink Partners reissued an “outperform” rating on shares of Cencora in a research report on Tuesday, March 17th. Citigroup decreased their price target on Cencora from $405.00 to $355.00 and set a “buy” rating for the company in a report on Thursday, May 7th. Morgan Stanley set a $342.00 price objective on Cencora in a report on Friday, May 8th. Robert W. Baird decreased their target price on Cencora from $420.00 to $339.00 and set an “outperform” rating for the company in a research note on Thursday, May 7th. Finally, Barclays lowered their price target on Cencora from $425.00 to $350.00 and set an “overweight” rating for the company in a report on Wednesday, June 10th. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $374.00.

Cencora Trading Down 0.1%

Shares of Cencora stock opened at $281.22 on Wednesday. The company has a fifty day simple moving average of $287.49 and a 200-day simple moving average of $326.05. Cencora, Inc. has a 12-month low of $244.82 and a 12-month high of $377.54. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. The stock has a market cap of $54.71 billion, a price-to-earnings ratio of 21.57, a PEG ratio of 1.52 and a beta of 0.59.

Cencora (NYSE:COR) last released its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing the consensus estimate of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The business had revenue of $78.36 billion during the quarter, compared to analysts’ expectations of $81.09 billion. During the same quarter last year, the company earned $4.42 EPS. The firm’s revenue for the quarter was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, equities analysts forecast that Cencora, Inc. will post 17.79 EPS for the current fiscal year.

Cencora Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were given a $0.60 dividend. The ex-dividend date was Friday, May 15th. This represents a $2.40 annualized dividend and a yield of 0.9%. Cencora’s dividend payout ratio is 18.40%.

Cencora declared that its Board of Directors has approved a share buyback program on Thursday, May 21st that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the company to buy up to 3.9% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board believes its shares are undervalued.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.